Explore the latest news, stories, and groundbreaking research happening at the Institute of Biomedical Engineering. Stay updated on innovative projects, impactful discoveries, and the achievements of our talented students, faculty, and alumni shaping the future of biomedical science and engineering.
Four researchers leading teams that are sharing $1 million in funding through the Pivotal Experiment Fund.
Dr. Omar Khan discuses Delta variant concerns being raised as Canada with Sonia Deol on Global News.
Dr. Michael Sefton had received ~ $430,000 JDRF grant to continue to study if cells found in the skin can play a key role in enabling stem cell transplants for diabetes.
Drs. Kei Masani, Sarah Vasconcelos, Sowmya Viswanathan, and Azadeh Yadollahi were both promoted to Associate Professor at the Institute of Biomedical Engineering (BME). This promotion was based on their research excellence, teaching mandates, and community- based contributions.
Researchers at the University of Toronto (Institute of Biomedical Engineering, Department of Chemistry, Donnelly Centre for Biomolecular Research) in collaboration with Sunnybrook Health Sciences Centre, Public Health Ontario, and Mt. Sinai Hospital have engineered a diagnostic test with a smartphone reader to surveil and track COVID-19 patients.
In a recent study, researchers from the University of Toronto employed a unique state-of-the-art imaging technique for deep tissue imaging, that has enabled the monitoring of peri-implant bony healing biology in action. This technology can lead to a better understanding of the healing process, allowing researchers to leverage this knowledge to develop faster therapeutic approaches with the use of biomaterials for the future.
An innovative biomaterial discovery by researchers at the University of Toronto in collaboration with Ripple Therapeutics Inc., has established a method that yields better control over drug release profiles in implants and has the potential to disrupt the classical drug delivery market.
Dr. Jose Zariffa and his research team are developing tools that enable clinicians to evaluate rehabilitation success and track recovery. The goal is to create a personalized process for the improvement of rehabilitation from spinal cord injuries and stroke, accelerating the affected individuals back on the road to recovery.
As Canada races to vaccinate its citizens amid an increase in variant infections, writer Liz Do spoke to Professor Omar F. Khan (BME), an immunoengineering expert. Khan, whose lab designs nanotechnology devices that can deliver RNA technology to cells for better disease treatment, explains common concerns and questions around COVID-19 vaccines.
Supported by U of T’s Medicine by Design initiative, a multidisciplinary team led by University Professor Molly Shoichet (ChemE, BME, Donnely) plans to use retinal stem cells to restore vision.
Scientists can now select individual cells from a population that grows on the surface of a laboratory dish and study their molecular contents. Developed by U of T researchers, the new tool will enable a deeper study of stem cells and other rare cell types for therapy development.
Paul Santerre, a professor in the Faculty of Dentistry and the Institute of Biomedical Engineering, says the extent of progress on diabetes and insulin will partly depend on how well research breakthroughs from scholars like Brubaker can be married with efforts at commercialization and innovation.
A team of researchers from U of T Engineering and the University of Michigan have redesigned and enhanced a natural enzyme that shows promise in promoting the regrowth of nerve tissue following injury.
A research team led by Dr. Eli Sone (BME, MSE, Dentistry) has discovered a new role in mineralization played by a class of molecules, glycosaminoglycans (GAGs)
U of T Engineering researchers have developed a new method of injecting healthy cells into damaged eyes. The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.
U of T Engineering researchers have discovered a dose threshold that greatly increases the delivery of cancer-fighting drugs into a tumour.
A group of researchers from the University of Toronto have developed a new tool to study breast cancer metastasis. By using a device that’s the size of a credit card, researchers can produce various biological environments to mimic the progression of cancer cell invasion.
The new joint centre on robotics for elder care is led by professors Alex Mihailidis (IBBME, Medicine) and Yan Fu at the Huazhong University of Science and Technology.
Brandon Rufino (IBBME MHSC candidate) will be presenting in the human health category as a lightning lecture speaker. Under the supervision of Professor Elaine Biddiss (IBBME), he and his fellow grad students develop and evaluate technologies to allow young people with disabilities to participate more meaningfully in arts, music, physical activities and therapies.
Testing for viruses is not a new science, but the COVID-19 pandemic has exposed the bottlenecks in established methods. Now, a team led by Professor Leo Chou (IBBME) is pursuing a non-traditional approach that, if successful, could lead to simpler, faster tests.
U of T researchers develop ‘piggyback’ vehicle to escape the endosomal trap and deliver RNA therapeutics
While most people are sheltering at home, for a team led by Professor Warren Chan it’s business as usual as they continue to develop an automated, more sensitive and rapid test for COVID-19 to help curb the pandemic.
The PRiME Task Force on Advanced Diagnostics and Therapeutics for COVID-19 brings together U of T researchers with expertise in a variety of fields to develop new diagnostic tools and therapeutics